|
|
||||||||
Ann Thorac Surg 1987;43:285-287
© 1987 The Society of Thoracic Surgeons
From the Departments of Surgery and Pediatrics, Deborah Heart and Lung Center, Browns Mills, NJ, and the Department of Surgery, University of Medicine and Dentistry of New Jersey, Rutgers Medical School, East Rutherford, NJ
Accepted for publication May 7, 1986.
* Address reprint requests to Dr. McGrath, Department of Surgery, Deborah Heart and Lung Center, Browns Mills, NJ 08015
To determine if anticoagulation therapy is necessary after valve replacement with the St. Jude Medical prosthesis in young subjects, 30 consecutive patients were studied. They ranged in age from 4 to 20 years, and each had undergone valve replacement some time between February, 1982, and June, 1984. There was 1 hospital death (3.3%; 70% confidence limits [CL] = 0.4% to 10.9%). The 29 hospital survivors were treated with aspirin and dipyridamole. All patients were followed up. There were 5 late deaths (17.2%; 70% CL = 9% to 27%), at a mean of 8 months postoperatively. Follow-up revealed that 7 thromboembolic events occurred in 7 of the hospital survivors (24.1%; 70% CL = 15% to 35%). Hemiparesis occurred in 1 patient, and documented valve thrombosis and death occurred in another. Transient sensorimotor deficits were found in the 5 other patients. Prosthetic valve endocarditis developed in 1 hospital survivor (3.5%; 70% CL = 0.4% to 11%) and resulted in late death. There were no reoperations in the hospital survivors. We conclude that the St. Jude Medical prosthesis is useful for valve replacement in the young because of its low profile, durability, and hemodynamic characteristics. However, we recommend that these patients receive full anticoagulation therapy.
This article has been cited by other articles:
![]() |
R. P. Whitlock, J. C. Sun, S. E. Fremes, F. D. Rubens, and K. H. Teoh Antithrombotic and Thrombolytic Therapy for Valvular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, February 1, 2012; 141(2_suppl): e576S - e600S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 593S - 629S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 457S - 482S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 645S - 687S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew Antithrombotic Therapy in Children Chest, January 1, 2001; 119(2009): 344S - 370S. [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud Anticoagulation in Children With Mechanical Valve Prostheses Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34. [Abstract] [Full Text] |
||||
![]() |
F. M. Lupinetti, J. Warner, T. K. Jones, and S. P. Herndon Comparison of Human Tissues and Mechanical Prostheses for Aortic Valve Replacement in Children Circulation, July 1, 1997; 96(1): 321 - 325. [Abstract] [Full Text] |
||||
![]() |
K. Hisatomi, T. Isomura, T. Sato, K. Kosuga, K. Ohishi, and H. Katoh Mitral Valve Repair for Mitral Regurgitation With Ventricular Septal Defect in Children Ann. Thorac. Surg., December 1, 1996; 62(6): 1773 - 1777. [Abstract] [Full Text] |
||||
![]() |
H. Pouleur and M. Buyse EFFECTS OF DIPYRIDAMOLE IN COMBINATION WITH ANTICOAGULANT THERAPY ON SURVIVAL AND THROMBOEMBOLIC EVENTS IN PATIENTS WITH PROSTHETIC HEART VALVESA meta-analysis of the randomized trials J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 463 - 472. [Abstract] [Full Text] |
||||
![]() |
M. Ibrahim, J. Cleland, H. O'Kane, D. Gladstone, C. Mullholland, and B. Craig St. Jude Medical prosthesis in children J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 52 - 56. [Abstract] [Full Text] |
||||
![]() |
J. Fernandez, G. W. Laub, M. S. Adkins, W. A. Anderson, C. Chen, B. M. Bailey, L. M. Nealon, and L. B. McGrath Early and late-phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 394 - 407. [Abstract] [Full Text] |
||||
![]() |
Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force Arch Neurol, July 1, 1989; 46(7): 727 - 743. [Abstract] [PDF] |
||||
![]() |
T. N. Zweng, M. K. Bluett, R. Mosca, L. B. Callow, and E. L. Bove Mitral valve replacement in the first 5 years of life Ann. Thorac. Surg., May 1, 1989; 47(5): 720 - 724. [Abstract] [PDF] |
||||
![]() |
R. McKay, J. Sono, and R. M. Arnold Tricuspid Valve Replacement Using an Unstented Pulmonary Homograft Ann. Thorac. Surg., July 1, 1988; 46(1): 58 - 62. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |